Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : The Stock for 1999(Polymedica)PLMD(Medical Supply Co.) -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (2520)	3/2/1999 4:44:00 PM
From: Sam	Respond to of 3414

Wasn't a downgrade. Oppenheimer is a new coverage and they came out with a buy reco. Because of the weird reporting formula that "buy" is valued at a "2" with strong buy as a "1". When added to the other buys and strong buys, this "buy" pulled the number down slightly.

To: Arthur Radley who wrote (2520)	3/2/1999 4:51:00 PM
From: Abuckatatime	Read Replies (1) \| Respond to of 3414

Not sure when it occurred and not sure exactly by whom but I'm guessing it was Josephthal. Sharon de Stefano, the analyst who provided the coverage there, has left the firm. I don't know if Josephthal will be contintuing coverage or whether de Stefano will continue covering PLMD from her new perch at Ryan, Beck & Co., although I doubt it since their equity coverage is primarily banks, trusts, and other financials. Currently I presume strong buys from Cruttenden and Branch Cabell and buys from Oppenheimer, Oscar Gruss, and Josephthal. Someone correct me if I'm wrong.